WCLC 2022 Conference Coverage
Playback speed
10 seconds
Lecture Summary - WCLC 2022 on the Phase II NAUTIKA1 Study of Targeted Therapies in Stage II-III NSCLC: Preliminary Data of Neoadjuvant Alectinib for ALK+ Disease
By
WCLC 2022 Conference Coverage
FEATURING
Jay Lee
By
WCLC 2022 Conference Coverage
FEATURING
Jay Lee
17 views
August 18, 2022
Comments 0
Login to view comments.
Click here to Login
Videos